Precision medicine: In vivo CAR therapy as a showcase for receptor-targeted vector platforms - ScienceDirect

Frontiers In-Vivo Induced CAR-T Cell for the Potential Breakthrough to Overcome the Barriers of Current CAR-T Cell Therapy

The expansion of targetable biomarkers for CAR T cell therapy, Journal of Experimental & Clinical Cancer Research

CAR models: next-generation CAR modifications for enhanced T-cell function: Molecular Therapy - Oncolytics

INSPIRED Symposium Part 2: Prevention and Management of Relapse Following Chimeric Antigen Receptor T Cell Therapy for B Cell Acute Lymphoblastic Leukemia - Transplantation and Cellular Therapy, Official Publication of the American

A new study urges CARe when considering multispecific CAR-T cell therapy

Frontiers Use of Cell and Genome Modification Technologies to Generate Improved “Off-the-Shelf” CAR T and CAR NK Cells

Targeted chemotherapy via HER2-based chimeric antigen receptor (CAR) engineered T-cell membrane coated polymeric nanoparticles - ScienceDirect

IJMS, Free Full-Text

In vivo CART cell imaging: Paving the way for success in CART cell therapy - ScienceDirect

In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo

Cancers, Free Full-Text

Mesothelin antigen density influences anti-mesothelin chimeric antigen receptor T cell cytotoxicity - Cytotherapy

Radionuclide-based molecular imaging allows CAR-T cellular visualization and therapeutic monitoring